AMB-CHMINACA

AMB-CHMINACA

Legal status
Legal status	CA: Schedule II DE: NpSG (Industrial and scientific use only) UK: Class B
Identifiers
IUPAC name methyl (2S)-2-{[1-(cyclohexylmethyl)indazole-3-carbonyl]amino}-3-methylbutanoate
CAS Number	1863066-03-8(racemate)
PubChem CID	119026010
ChemSpider	32055578
UNII	OU56JJP891 Y21A13WADY(racemate)
E number	{{#property:P628}}
CompTox Dashboard (EPA)	{{#property:P3117}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C21H29N3O3
Molar mass	371.481 g·mol−1
3D model (JSmol)	Interactive image
SMILES COC([C@H](C(C)C)NC(C1=NN(C2=C1C=CC=C2)CC3CCCCC3)=O)=O
InChI InChI=1S/C21H29N3O3/c1-14(2)18(21(26)27-3)22-20(25)19-16-11-7-8-12-17(16)24(23-19)13-15-9-5-4-6-10-15/h7-8,11-12,14-15,18H,4-6,9-10,13H2,1-3H3,(H,22,25)/t18-/m0/s1 Key:CRGGXDSTBHQLKJ-SFHVURJKSA-N

AMB-CHMINACA or MMB-CHMINACA (also known as MA-CHMINACA) is an indazole-based synthetic cannabinoid that is a potent agonist of the CB₁ receptor and has been sold online as a designer drug.

Legal status

AMB-CHMINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.

Sweden's public health agency classified AMB-CHMINACA as a narcotic substance, on January 18, 2019.

See also

• 5F-AB-PINACA
• 5F-ADB
• 5F-AMB
• 5F-APINACA
• AB-CHFUPYCA
• AB-FUBINACA
• AB-PINACA
• ADB-CHMINACA
• ADB-FUBINACA
• ADB-PINACA
• ADSB-FUB-187
• AMB-FUBINACA
• APINACA
• MDMB-CHMICA
• MDMB-CHMINACA
• MDMB-FUBINACA
• PX-2
• PX-3